Your browser doesn't support javascript.
loading
Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia.
Schnettler, W T; Dukhovny, D; Wenger, J; Salahuddin, S; Ralston, S J; Rana, S.
Afiliação
  • Schnettler WT; Division of Maternal-Fetal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
BJOG ; 120(10): 1224-32, 2013 Sep.
Article em En | MEDLINE | ID: mdl-23647884
ABSTRACT

OBJECTIVES:

To analyse the economic and resource implications of using plasma soluble fms-like tyrosine kinase-1 s(Flt1) and placenta growth factor (PlGF) measurements in pre-eclampsia evaluation and management.

DESIGN:

Retrospective cost analysis of our prospective cohort study.

SETTING:

Boston, Massachusetts (USA). POPULATION Women (n = 176) presenting to the hospital at <34 weeks of gestation for evaluation of possible pre-eclampsia during 2009-10. Cases without complete cost or outcome data (n = 9) and re-enrolments (n = 18) were excluded.

METHODS:

Modelled comparisons between the standard approach (combination of blood pressure, urinary protein excretion, alanine aminotransferase and platelet counts) and a novel approach (ratio of plasma sFlt1 and PlGF) using actual hospital data converted to 2012 US dollars in accordance with the Centers for Medicare and Medicaid Services. MAIN OUTCOME

MEASURES:

Direct 2-week costs and resource use by groups having true or false positive and negative test results for adverse outcomes according to approach.

RESULTS:

The improved specificity of the novel approach decreased the proportion of women falsely labelled as test-positive from 42.3% (34.4-50.2%) to 4.0% (0.85-7.15%) and increased the proportion correctly labelled as test-negative from 23.5% (16.7-30.3%) to 61.7% (53.9-69.5%). This could potentially reduce average per-patient costs by $1215. Substantial quantities of resources [47.2% (35.7-58.7%) of antenatal admissions and 72.5% (68.0-77.0%) of tests for fetal wellbeing] were unnecessarily used for women who were truly negative. A proportion of iatrogenic preterm deliveries among women with negative results was potentially avoidable representing further cost and resource savings.

CONCLUSIONS:

Clinical use of the plasma sFlt1 and PlGF ratio improves risk stratification among women presenting for pre-eclampsia evaluation and has the potential to reduce costs and resource use.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Proteínas da Gravidez / Custos de Cuidados de Saúde / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Recursos em Saúde Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: BJOG Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Proteínas da Gravidez / Custos de Cuidados de Saúde / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Recursos em Saúde Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: BJOG Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos